Dymon Asia Capital (Singapore)’s Insmed INSM Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,540	Closed	-$442K	–	274
2025 Q4	$442K	Buy	+2,540	New	+$463K	0.04%	203

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s INSM Position: Q1 2026 in Review

Dymon Asia Capital (Singapore) sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,540 shares — an estimated $442K sold.

Dymon Asia Capital (Singapore) first reported a position in INSM in Q4 2025 and held it in 1 quarter. The position peaked at $442K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Dymon Asia Capital (Singapore) reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Dymon Asia Capital (Singapore) sold 2,540 Insmed shares in Q1 2026, an estimated $442K.
Dymon Asia Capital (Singapore) first reported a position in Insmed in Q4 2025 and held it in 1 quarter.
Dymon Asia Capital (Singapore)'s Insmed position peaked at $442K in Q4 2025.
673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q1 2026, filed 14 May 2026.